12.85 USD
+0.09 (+0.71%)
12.85 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to EMBC. EMBC was compared to 185 industry peers in the Health Care Equipment & Supplies industry. EMBC has an excellent profitability rating, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on EMBC.
1. Profitability
1.1 Basic Checks
In the past year EMBC was profitable.
In the past year EMBC had a positive cash flow from operations.
EMBC had positive earnings in each of the past 5 years.
EMBC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
EMBC's Return On Assets of 8.75% is amongst the best of the industry. EMBC outperforms 90.81% of its industry peers.
EMBC's Return On Invested Capital of 27.81% is amongst the best of the industry. EMBC outperforms 98.92% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EMBC is significantly above the industry average of 8.84%.
The 3 year average ROIC (22.63%) for EMBC is below the current ROIC(27.81%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.75% | ||
| ROE | N/A | ||
| ROIC | 27.81% |
ROA(3y)6.88%
ROA(5y)18.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)22.63%
ROIC(5y)31.94%
1.3 Margins
EMBC's Profit Margin of 8.83% is amongst the best of the industry. EMBC outperforms 81.62% of its industry peers.
In the last couple of years the Profit Margin of EMBC has declined.
EMBC has a Operating Margin of 30.50%. This is amongst the best in the industry. EMBC outperforms 97.30% of its industry peers.
EMBC's Operating Margin has declined in the last couple of years.
The Gross Margin of EMBC (63.85%) is better than 65.95% of its industry peers.
EMBC's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 30.5% | ||
| PM (TTM) | 8.83% | ||
| GM | 63.85% |
OM growth 3Y-5.72%
OM growth 5Y-7.43%
PM growth 3Y-23.59%
PM growth 5Y-25.86%
GM growth 3Y-2.36%
GM growth 5Y-1.89%
2. Health
2.1 Basic Checks
EMBC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
EMBC has more shares outstanding than it did 1 year ago.
The number of shares outstanding for EMBC has been increased compared to 5 years ago.
The debt/assets ratio for EMBC is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.08 indicates that EMBC is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of EMBC (2.08) is better than 61.08% of its industry peers.
The Debt to FCF ratio of EMBC is 7.84, which is on the high side as it means it would take EMBC, 7.84 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.84, EMBC is in the better half of the industry, outperforming 74.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 7.84 | ||
| Altman-Z | 2.08 |
ROIC/WACC3.3
WACC8.42%
2.3 Liquidity
EMBC has a Current Ratio of 2.41. This indicates that EMBC is financially healthy and has no problem in meeting its short term obligations.
EMBC has a Current ratio (2.41) which is comparable to the rest of the industry.
EMBC has a Quick Ratio of 1.73. This is a normal value and indicates that EMBC is financially healthy and should not expect problems in meeting its short term obligations.
EMBC has a Quick ratio (1.73) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.73 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 20.24% over the past year.
Measured over the past years, EMBC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -26.21% on average per year.
Looking at the last year, EMBC shows a decrease in Revenue. The Revenue has decreased by -3.80% in the last year.
Measured over the past years, EMBC shows a decrease in Revenue. The Revenue has been decreasing by -0.10% on average per year.
EPS 1Y (TTM)20.24%
EPS 3Y-25.33%
EPS 5Y-26.21%
EPS Q2Q%11.11%
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y-1.47%
Revenue growth 5Y-0.1%
Sales Q2Q%-7.72%
3.2 Future
EMBC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.66% yearly.
Based on estimates for the next years, EMBC will show a small growth in Revenue. The Revenue will grow by 1.59% on average per year.
EPS Next Y-0.06%
EPS Next 2Y0.71%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y0.05%
Revenue Next 3Y0.21%
Revenue Next 5Y1.59%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 4.33 indicates a rather cheap valuation of EMBC.
98.92% of the companies in the same industry are more expensive than EMBC, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.25, EMBC is valued rather cheaply.
EMBC is valuated cheaply with a Price/Forward Earnings ratio of 4.33.
Based on the Price/Forward Earnings ratio, EMBC is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
EMBC is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.98, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.33 | ||
| Fwd PE | 4.33 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EMBC is valued cheaply inside the industry as 98.38% of the companies are valued more expensively.
100.00% of the companies in the same industry are more expensive than EMBC, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.12 | ||
| EV/EBITDA | 5.27 |
4.3 Compensation for Growth
EMBC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.71%
EPS Next 3Y0.66%
5. Dividend
5.1 Amount
EMBC has a Yearly Dividend Yield of 4.70%, which is a nice return.
EMBC's Dividend Yield is rather good when compared to the industry average which is at 0.19. EMBC pays more dividend than 99.46% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.92, EMBC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.7% |
5.2 History
EMBC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
36.69% of the earnings are spent on dividend by EMBC. This is a low number and sustainable payout ratio.
DP36.69%
EPS Next 2Y0.71%
EPS Next 3Y0.66%
12.85
+0.09 (+0.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners99.49%
Inst Owner Change0.83%
Ins Owners1.29%
Ins Owner Change28.53%
Market Cap751.85M
Revenue(TTM)1.08B
Net Income(TTM)95.40M
Analysts51.11
Price Target17 (32.3%)
Short Float %5.84%
Short Ratio5.72
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.7% |
Yearly Dividend0.6
Dividend Growth(5Y)N/A
DP36.69%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.51%
Min EPS beat(2)-8.66%
Max EPS beat(2)41.68%
EPS beat(4)3
Avg EPS beat(4)26.75%
Min EPS beat(4)-8.66%
Max EPS beat(4)44.01%
EPS beat(8)7
Avg EPS beat(8)35.11%
EPS beat(12)9
Avg EPS beat(12)26.08%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.77%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)4.13%
Revenue beat(4)2
Avg Revenue beat(4)0.59%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)4.13%
Revenue beat(8)5
Avg Revenue beat(8)1.57%
Revenue beat(12)9
Avg Revenue beat(12)1.87%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.96%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.47%
Revenue NQ rev (1m)-1.15%
Revenue NQ rev (3m)-2.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.33 | ||
| Fwd PE | 4.33 | ||
| P/S | 0.7 | ||
| P/FCF | 4.12 | ||
| P/OCF | 3.92 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.27 |
EPS(TTM)2.97
EY23.11%
EPS(NY)2.97
Fwd EY23.1%
FCF(TTM)3.12
FCFY24.26%
OCF(TTM)3.28
OCFY25.5%
SpS18.47
BVpS-11.12
TBVpS-11.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.75% | ||
| ROE | N/A | ||
| ROCE | 39.73% | ||
| ROIC | 27.81% | ||
| ROICexc | 38.19% | ||
| ROICexgc | 39.66% | ||
| OM | 30.5% | ||
| PM (TTM) | 8.83% | ||
| GM | 63.85% | ||
| FCFM | 16.88% |
ROA(3y)6.88%
ROA(5y)18.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)22.63%
ROIC(5y)31.94%
ROICexc(3y)32.83%
ROICexc(5y)43.39%
ROICexgc(3y)34.19%
ROICexgc(5y)45.56%
ROCE(3y)32.33%
ROCE(5y)45.63%
ROICexgc growth 3Y-16%
ROICexgc growth 5Y-7.86%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y-7.62%
OM growth 3Y-5.72%
OM growth 5Y-7.43%
PM growth 3Y-23.59%
PM growth 5Y-25.86%
GM growth 3Y-2.36%
GM growth 5Y-1.89%
F-Score6
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 7.84 | ||
| Debt/EBITDA | 3.83 | ||
| Cap/Depr | 22.85% | ||
| Cap/Sales | 0.86% | ||
| Interest Coverage | 3.17 | ||
| Cash Conversion | 51.78% | ||
| Profit Quality | 191.2% | ||
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.73 | ||
| Altman-Z | 2.08 |
F-Score6
WACC8.42%
ROIC/WACC3.3
Cap/Depr(3y)49.26%
Cap/Depr(5y)65.23%
Cap/Sales(3y)1.54%
Cap/Sales(5y)2.02%
Profit Quality(3y)91.71%
Profit Quality(5y)109.85%
High Growth Momentum
Growth
EPS 1Y (TTM)20.24%
EPS 3Y-25.33%
EPS 5Y-26.21%
EPS Q2Q%11.11%
EPS Next Y-0.06%
EPS Next 2Y0.71%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y-1.47%
Revenue growth 5Y-0.1%
Sales Q2Q%-7.72%
Revenue Next Year0%
Revenue Next 2Y0.05%
Revenue Next 3Y0.21%
Revenue Next 5Y1.59%
EBIT growth 1Y47.56%
EBIT growth 3Y-7.11%
EBIT growth 5Y-7.53%
EBIT Next Year15.9%
EBIT Next 3Y4.95%
EBIT Next 5YN/A
FCF growth 1Y816.58%
FCF growth 3Y-22.26%
FCF growth 5Y-16.78%
OCF growth 1Y436.98%
OCF growth 3Y-22.52%
OCF growth 5Y-17.41%
EMBECTA CORP / EMBC FAQ
What is the fundamental rating for EMBC stock?
ChartMill assigns a fundamental rating of 6 / 10 to EMBC.
What is the valuation status for EMBC stock?
ChartMill assigns a valuation rating of 8 / 10 to EMBECTA CORP (EMBC). This can be considered as Undervalued.
Can you provide the profitability details for EMBECTA CORP?
EMBECTA CORP (EMBC) has a profitability rating of 7 / 10.
What are the PE and PB ratios of EMBECTA CORP (EMBC) stock?
The Price/Earnings (PE) ratio for EMBECTA CORP (EMBC) is 4.33 and the Price/Book (PB) ratio is -1.16.
Can you provide the expected EPS growth for EMBC stock?
The Earnings per Share (EPS) of EMBECTA CORP (EMBC) is expected to decline by -0.06% in the next year.